simvastatin has been researched along with Hyperglycemia, Postprandial in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y; Meng, L; Sun, Z; Zhou, P | 1 |
| Ni, Y; Sun, Z; Wang, Z; Xu, H; Zheng, L | 1 |
| Al-Ajmi, HN; Al-Amin, MA; Al-Rasheed, NM; Bassiouni, YA; Hasan, IH; Mahmoud, AM | 1 |
| Babu, PP; Kapadia, B; Mandaliya, D; Misra, P; Muggalla, CS; Patel, S; Prajapati, B; Rapaka, N; Saxena, U; Seshadri, S | 1 |
| Anderson, MS; Engel, SS; Hanson, ME; Musliner, T; Steinberg, H | 1 |
| Ahlquist, P; Bagdat, D; Blegvad, J; Christensen, R; Christensen, TG; Colic, A; Ellingsen, T; Emmertsen, H; Fredberg, U; Giraldi, A; Graugaard, C; Hansen, IM; Hørslev-Petersen, K; Jensen, HS; Løgstrup, BB; Persson, F; Sheetal, E; Svendsen, L; Svensson, AL; Thygesen, T | 1 |
| Catapano, AL; Farnier, M; Foody, J; Hanson, ME; Jensen, E; Musliner, TA; Polis, AB; Tershakovec, AM; Tomassini, JE; Toth, PP | 1 |
| Kowluru, A; Sidarala, V | 1 |
| Aoyama, I; Bomsztyk, K; Komers, R; Koopmeiners, JS; Naito, M; Schnaper, HW; Shenoy, A | 1 |
| de Haan, RJ; Kruyt, ND; Roos, YB; van Geloven, N; Vergouwen, MD; Vermeulen, M | 1 |
| Ambrosius, WT; Chew, EY; Cushman, WC; Danis, RP; Davis, MD; Elam, MB; Esser, BA; Fine, LJ; Gangaputra, S; Genuth, S; Gerstein, HC; Ginsberg, HN; Goff, DC; Greven, CM; Hubbard, L; Lovato, JF; Perdue, LH; Schubart, U | 1 |
| Oroma Owira, PM; Xulu, S | 1 |
| Ceriello, A | 1 |
| Assaloni, R; Ceriello, A; Da Ros, R; Esposito, K; Giugliano, D; Maier, A; Piconi, L; Quagliaro, L | 1 |
| Wang, YX | 1 |
| Gu, W; Kehl, F; Kersten, JR; Krolikowski, JG; Pagel, PS; Warltier, DC | 1 |
| Böhm, F; Pernow, J; Rydén, L; Settergren, M | 1 |
3 review(s) available for simvastatin and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.
Topics: Biomarkers; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Lipids; Pyrazines; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2013 |
Nitrotyrosine: new findings as a marker of postprandial oxidative stress.
Topics: Animals; Biomarkers; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hyperglycemia; Hypertriglyceridemia; Hypolipidemic Agents; Oxidative Stress; Postprandial Period; Rats; Simvastatin; Tyrosine | 2002 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
5 trial(s) available for simvastatin and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Denmark; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Severity of Illness Index; Simvastatin; Young Adult | 2016 |
Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Blood Glucose; Brain Ischemia; Combined Modality Therapy; Double-Blind Method; Embolization, Therapeutic; Endothelium, Vascular; Female; Glasgow Coma Scale; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypertension; Male; Middle Aged; Neurologic Examination; Prognosis; Simvastatin; Subarachnoid Hemorrhage, Traumatic; Surgical Instruments; von Willebrand Factor | 2010 |
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Follow-Up Studies; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Simvastatin | 2010 |
Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.
Topics: Body Mass Index; Cross-Over Studies; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; E-Selectin; Electrocardiography; Female; Humans; Hyperglycemia; Hypertriglyceridemia; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Male; Middle Aged; Oxidative Stress; Postprandial Period; Simvastatin; Triglycerides; Tyrosine; Vascular Cell Adhesion Molecule-1 | 2004 |
Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
Topics: Aged; Azetidines; Brachial Artery; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Inflammation Mediators; Lipids; Male; Middle Aged; Plethysmography; Regional Blood Flow; Simvastatin; Vasodilation | 2008 |
9 other study(ies) available for simvastatin and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Simvastatin inhibites high glucose-induced renal tubular epithelial cells apoptosis by down-regulating miR-92a.
Topics: Apoptosis; Cell Line; Cell Survival; Diabetic Nephropathies; Down-Regulation; Epithelial Cells; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Kidney Tubules; MicroRNAs; Simvastatin | 2021 |
GATA4 protects against hyperglycemia‑induced endothelial dysfunction by regulating NOX4 transcription.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Induction; GATA4 Transcription Factor; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Male; Mice, Inbred C57BL; NADPH Oxidase 4; Nitric Oxide; Simvastatin | 2018 |
Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Caspase 3; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Hyperglycemia; Hypertrophy; Kidney; Kidney Function Tests; Male; Oxidative Stress; Rats, Wistar; Simvastatin; Streptozocin | 2018 |
Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model.
Topics: Animals; Atorvastatin; Diet; Disease Models, Animal; Fatty Acids; Feeding Behavior; Gene Expression Regulation; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Insulin; Muscles; Rats; Signal Transduction; Simvastatin; Sucrose | 2019 |
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Comorbidity; Drug Therapy, Combination; Ezetimibe; Fasting; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 2016 |
Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Morpholines; p38 Mitogen-Activated Protein Kinases; Prenylation; Pyridines; Pyrones; Quinolines; rac1 GTP-Binding Protein; Rats; Simvastatin; Tumor Suppressor Protein p53 | 2017 |
High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.
Topics: Angiotensin II; Gene Expression Regulation; Glucose; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Inflammation; Kidney; Mesangial Cells; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Tetrazoles; Valine; Valsartan | 2009 |
Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes.
Topics: Animals; Atherosclerosis; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dyslipidemias; Flavanones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Wistar; Simvastatin; Streptozocin | 2012 |
Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism.
Topics: Animals; Blood Glucose; Dogs; Female; Hyperglycemia; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Nitric Oxide; Simvastatin | 2008 |